Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells. - Bopp AR; Lamenza FF; Upadhaya P; Ryan NM; Kazmierowicz N; Jordanides PP; Siddiqui A; Pracha SH; Roth P; Iwenofu OH; Oghumu S (Cancer immunology, immunotherapy : CII, 2025)